HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.

AbstractBACKGROUND:
Previous studies suggest that L-arginine, an amino acid and a substrate of nitric oxide synthase, may have blood pressure (BP)-lowering effect. Because some studies were performed with limited number of patients with hypertension and therefore limited statistical power with sometimes inconsistent results, we aimed to examine the effect of oral L-arginine supplementation on BP by conducting a meta-analysis of randomized, double-blind, placebo-controlled trials.
METHODS:
PubMed, Cochrane Central Register of Controlled Trials, and the ClinicalTrials.gov databases were searched through June 2011 to identify randomized, double-blind, placebo-controlled trials of oral L-arginine supplementation on BP in humans. We also reviewed reference lists of obtained articles. Either a fixed-effects or, in the presence of heterogeneity, a random-effects model was used to calculate the combined treatment effect.
RESULTS:
We included 11 randomized, double-blind, placebo-controlled trials involving 387 participants with oral L-arginine intervention ranging from 4 to 24 g/d. Compared with placebo, L-arginine intervention significantly lowered systolic BP by 5.39 mm Hg (95% CI -8.54 to -2.25, P = .001) and diastolic BP by 2.66 mm Hg (95% CI -3.77 to -1.54, P < .001). Sensitivity analyses restricted to trials with a duration of 4 weeks or longer and to trials in which participants did not use antihypertensive medications yielded similar results. Meta-regression analysis suggested an inverse, though insignificant (P = .13), relation between baseline systolic BP and net change in systolic BP.
CONCLUSIONS:
This meta-analysis provides further evidence that oral L-arginine supplementation significantly lowers both systolic and diastolic BP.
AuthorsJia-Yi Dong, Li-Qiang Qin, Zengli Zhang, Youyou Zhao, Junkuan Wang, Fabrizio Arigoni, Weiguo Zhang
JournalAmerican heart journal (Am Heart J) Vol. 162 Issue 6 Pg. 959-65 (Dec 2011) ISSN: 1097-6744 [Electronic] United States
PMID22137067 (Publication Type: Journal Article, Meta-Analysis, Review)
CopyrightCopyright © 2011 Mosby, Inc. All rights reserved.
Chemical References
  • Antihypertensive Agents
  • Arginine
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Antihypertensive Agents (administration & dosage)
  • Arginine (administration & dosage)
  • Blood Pressure (drug effects)
  • Dietary Supplements
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: